Latest Enbrel news
Infection Risk Lower for Etanercept Vs Monoclonal Ab Rx
by modernClinician Editorial Team
For patients with rheumatoid arthritis, etanercept is associated with lower risk for general infections and tuberculosis compared with monoclonal antibody treatment, according to a meta-analysis published online Feb. 3 in the International Journal of Rheumatic Diseases.
Study Compares Effectiveness of Biologics in Psoriasis Treatment
by modernClinician Editorial Team
For patients with psoriasis, ustekinumab has the highest effectiveness over five years of treatment and adalimumab and ustekinumab more often reach a 75 percent reduction in Psoriasis Area Severity Index compared to baseline than etanercept, according to a study published online Aug. 31 in the British Journal of Dermatology.
FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis
by modernClinician Editorial Team
A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease Related Articles
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 Monthly Specialist Briefings
Stay Connected
